| http://www.w3.org/ns/prov#value | - Antibodies and other ligands that bind to CD46 and other complement receptors may be developed for treatment of a variety of auto-immune disorders, including arthritis, graft-versus-host disease, lupus, multiple sclerosis and Crohn's disease.
|
